157 related articles for article (PubMed ID: 31976753)
1. The Use of Sleep Medication in Youth Residential Care.
Oerbeck B; Overgaard KR; Hjellvik V; Bramness JG; Hansen BH; Lien L
J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):335-341. PubMed ID: 31976753
[No Abstract] [Full Text] [Related]
2. The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care.
Oerbeck B; Overgaard KR; Hjellvik V; Lien L; Bramness JG
J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):350-357. PubMed ID: 33635152
[No Abstract] [Full Text] [Related]
3. Psychotropic Medication Prescription Rates and Trends for New Zealand Children and Adolescents 2008-2016.
Barczyk ZA; Rucklidge JJ; Eggleston M; Mulder RT
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):87-96. PubMed ID: 31633377
[No Abstract] [Full Text] [Related]
4. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.
Ohayon MM; Lader MH
J Clin Psychiatry; 2002 Sep; 63(9):817-25. PubMed ID: 12363124
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic medication use in French children and adolescents.
Kovess V; Choppin S; Gao F; Pivette M; Husky M; Leray E
J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):168-75. PubMed ID: 25584837
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.
Hartz I; Skurtveit S; Steffenak AK; Karlstad Ø; Handal M
BMC Psychiatry; 2016 Jan; 16():12. PubMed ID: 26822371
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns.
Koelch M; Prestel A; Singer H; Keller F; Fegert JM; Schlack R; Hoelling H; Knopf H
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):765-70. PubMed ID: 20035595
[TBL] [Abstract][Full Text] [Related]
10. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
12. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
13. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
Hirano Y; Ii Y
Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study.
Gómez-Lumbreras A; Garcia Sangenis A; Prat Vallverdú O; Gatell Carbó A; Vedia Urgell C; Gisbert Gustemps L; Bruna Pérez X; Ramos Quiroga A; Morros Pedrós R
Psychopharmacology (Berl); 2021 Jul; 238(7):1805-1815. PubMed ID: 33694030
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database.
Kjosavik SR; Ruths S; Hunskaar S
Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):572-8. PubMed ID: 19402032
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
17. Prescription of psychotropic medications to youths in office-based practice.
Goodwin R; Gould MS; Blanco C; Olfson M
Psychiatr Serv; 2001 Aug; 52(8):1081-7. PubMed ID: 11474055
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic Medication Patterns for American Indian Children in Foster Care.
Glesener D; Anderson G; Li X; Brown J; Amell J; Regal R; Ferguson D
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):225-231. PubMed ID: 29425063
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic medication consumption patterns in the UK general population.
Ohayon MM; Caulet M; Priest RG; Guilleminault C
J Clin Epidemiol; 1998 Mar; 51(3):273-83. PubMed ID: 9495693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
